antazoline   Click here for help

GtoPdb Ligand ID: 7116

Approved drug
antazoline is an approved drug
Compound class: Synthetic organic
Comment: There is no information regarding approval for clinical use of this drug on the US FDA website. Other national approval agencies may have granted marketing authorisation.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 3
Hydrogen bond donors 1
Rotatable bonds 5
Topological polar surface area 27.63
Molecular weight 265.16
XLogP 3.37
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES c1ccc(cc1)CN(c1ccccc1)CC1=NCCN1
Isomeric SMILES c1ccc(cc1)CN(c1ccccc1)CC1=NCCN1
InChI InChI=1S/C17H19N3/c1-3-7-15(8-4-1)13-20(14-17-18-11-12-19-17)16-9-5-2-6-10-16/h1-10H,11-14H2,(H,18,19)
InChI Key REYFJDPCWQRWAA-UHFFFAOYSA-N
No information available.
Summary of Clinical Use Click here for help
There is no information regarding approval for clinical use of this drug on the US FDA website. Other national approval agencies may have granted marketing authorisation.
Antazoline is contained in brand mixture eye drops, in combination with xylometazoline (Otrivine antistin®) or naphazoline (Vasocon-A®) used for temporary relief of allergic conjunctivitis.
Mechanism Of Action and Pharmacodynamic Effects Click here for help
Antazoline blocks the action of endogenous histamine at the histamine H1 receptor.
External links Click here for help